GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Caplin Point Laboratories Ltd (BOM:524742) » Definitions » Equity-to-Asset

Caplin Point Laboratories (BOM:524742) Equity-to-Asset : 0.86 (As of Mar. 2024)


View and export this data going back to 2001. Start your Free Trial

What is Caplin Point Laboratories Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Caplin Point Laboratories's Total Stockholders Equity for the quarter that ended in Mar. 2024 was ₹23,157 Mil. Caplin Point Laboratories's Total Assets for the quarter that ended in Mar. 2024 was ₹26,974 Mil. Therefore, Caplin Point Laboratories's Equity to Asset Ratio for the quarter that ended in Mar. 2024 was 0.86.

The historical rank and industry rank for Caplin Point Laboratories's Equity-to-Asset or its related term are showing as below:

BOM:524742' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.34   Med: 0.84   Max: 0.87
Current: 0.86

During the past 13 years, the highest Equity to Asset Ratio of Caplin Point Laboratories was 0.87. The lowest was 0.34. And the median was 0.84.

BOM:524742's Equity-to-Asset is ranked better than
89.23% of 1086 companies
in the Drug Manufacturers industry
Industry Median: 0.58 vs BOM:524742: 0.86

Caplin Point Laboratories Equity-to-Asset Historical Data

The historical data trend for Caplin Point Laboratories's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Caplin Point Laboratories Equity-to-Asset Chart

Caplin Point Laboratories Annual Data
Trend Jun15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.84 0.87 0.86 0.86 0.86

Caplin Point Laboratories Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.86 - 0.86 - 0.86

Competitive Comparison of Caplin Point Laboratories's Equity-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, Caplin Point Laboratories's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Caplin Point Laboratories's Equity-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Caplin Point Laboratories's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Caplin Point Laboratories's Equity-to-Asset falls into.



Caplin Point Laboratories Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Caplin Point Laboratories's Equity to Asset Ratio for the fiscal year that ended in Mar. 2024 is calculated as

Equity to Asset (A: Mar. 2024 )=Total Stockholders Equity/Total Assets
=23157/26973.8
=0.86

Caplin Point Laboratories's Equity to Asset Ratio for the quarter that ended in Mar. 2024 is calculated as

Equity to Asset (Q: Mar. 2024 )=Total Stockholders Equity/Total Assets
=23157/26973.8
=0.86

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Caplin Point Laboratories  (BOM:524742) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Caplin Point Laboratories Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Caplin Point Laboratories's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Caplin Point Laboratories (BOM:524742) Business Description

Traded in Other Exchanges
Address
Ashvich Tower, Developed Plots Industrial Estate, No. 3, 3rd Floor, Perungudi, Chennai, TN, IND, 600 096
Caplin Point Laboratories Ltd is the India-based pharmaceutical company. It is engaged in the manufacturing and marketing of pharmaceutical products. The company's key products include tablets, capsules, liquid orals, dry powder, soft gels, penems injections, suppositories. It also provides pharmaceutical formulations in specialized injectable dosage forms and Ophthalmic drops. The business of the company is organized into the following product segments, Antibiotics, Nsaids, Ophthalmics, Pain Management, and Antiulcers. Its products have a presence in the Latin American and African markets.

Caplin Point Laboratories (BOM:524742) Headlines

No Headlines